CONCENTRA GROUP HOLDINGS PARENT IN (CON)
Health Care · healthcare facilities / medical clinics · NYSE
Concentra is a leading provider of occupational health and urgent care services across a national network of medical centers.
What CONCENTRA GROUP HOLDINGS PARENT IN does
Concentra Group Holdings Parent, Inc. provides occupational medicine and urgent care services. The company operates a national network of medical centers, delivering health services primarily to employees and employers, including injury care, physical therapy, and occupational health testing.
Themes: occupational health, urgent care, physical therapy services
Fundamentals
- Price$34.99 as of 2026-08-24 close
- Market cap$4.5B as of 2026-08-24
- 1-year return+47.9% 2025-08-22 close $23.65 → 2026-08-24 close $34.99
- P/E25.23 as of 2026-08-24
- Net margin+8.0% as of 2026-08-24
- Gross margin+28.7% as of 2026-08-24
- ROE+46.1% as of 2026-08-24
- Debt / equity3.71 as of 2026-08-24
- Revenue growth (YoY)+15.5% as of 2026-08-24
- Revenue CAGR (3y)+7.9% SEC XBRL
- Beta0.69 as of 2026-08-24
- Last reported earnings2026-08-06 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +0.9%; at least 2 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How CON compares in its sector
- price-to-earnings ratiomiddle range 191 covered Health Care peers, as of 2026-08-24
- net profit margintop 25% 504 covered Health Care peers, as of 2026-08-24
- operating margintop 25% 504 covered Health Care peers, as of 2026-08-24
- gross marginbottom 25% 384 covered Health Care peers, as of 2026-08-24
- return on equitytop 10% 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- indicated dividend yieldmiddle range 71 covered Health Care peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)top 25% 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
CON is not currently in any published Top 10 list. Its scores are below.
Long-term score
56.4 #283 of 987 scored · #14 of 57 in Health Care
Long-term trend 84th (trading above its 200-day average) and growth 70th (revenue growth year over year 15.5%, 3-year revenue CAGR 7.9%); weakest is capital return (21st, consecutive years of dividend increases 2 years).
Short-term score
63.1 #92 of 1,704 scored · #26 of 240 in Health Care
Volume and participation 77th: it gapped 12.2% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed; trend 76th: a strong uptrend, with buyers in control; weakest is setup 45th: over the past year its closes ranged, and it has retraced only a small part of its move over the past year — 3% of it.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, CON's dividend was covered by reported results (earnings payout 19%, free-cash-flow payout 16%). This describes past coverage, not a forecast.
- Earnings payout19% dividends / net income
- Free-cash-flow payout16% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How CONCENTRA GROUP HOLDINGS PARENT IN looks technically
CONCENTRA GROUP HOLDINGS PARENT IN (CON) is trading 43.6% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 126 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 29, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 65, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 10 trading days ago (its momentum flipped positive). It made a new 20-day high about 5 trading days ago. It is 2.5% below its all-time high.
Trend
8
| Distance from the 200-day | it is trading 43.6% above its 200-day average, the long-term trend line — a longer-term uptrend | +43.6% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $31.47 | $31.47 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $24.37 | $24.37 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing low 15 calendar days ago — the swings before that are what the structure reading is measured on | 15 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes below 30.125. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible upward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 126 trading days ago — a "golden cross", a bullish long-term signal | 126 sessions |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 29, with buyers in control | 29.1 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 65, neither overbought (above 70) nor oversold (below 30) | 65.4 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($30.13 to $35.90) — its "stochastic" reading is 84 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 84.4 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 10 trading days ago (its momentum flipped positive) | 10 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $35.90 | $35.90 |
|---|---|---|
| From the 52-week high | it is 2.5% below its 52-week high (its highest price of the past year) | -2.5% |
| Above the 52-week low | it is 88.7% above its 52-week low (its lowest price of the past year) | +88.7% |
| Below the 52-week high | it is 2.5% below its highest point of the past year | 2.5% |
| Since a 20-day breakout | it made a new 20-day high about 5 trading days ago | 5 sessions |
| Since a 55-day breakout | it made a new 55-day high about 5 trading days ago | 5 sessions |
| All-time high | its highest closing price on record is $35.90 (set on 2026-08-18) | $35.90 |
| Given back of the 52-week move | over the past year its closes ranged ($18.71 to $35.53), and it has given back only a small part of its rise from last year’s low — 3% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $24.60 to $25.14. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 3.1% |
| From the all-time high | it is 2.5% below its all-time high | -2.5% |
| Nearest price level | it is trading 7.8% above a support level at $32.27 — a price it turned at twice since 2026-07-06, most recently on 2026-07-16. Since 2024-08-21 it has 11 such levels below the current price and 0 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -7.8% |
| All-time low | its lowest closing price on record is $18.55 (set on 2025-11-06) | $18.55 |
| Above the all-time low | it is 88.7% above its all-time low | +88.7% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 81% of the past ~6 months) | 81st percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.04 between its high and its low — about 3.0% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.04 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $29.84 and $36.66 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $29.84 – $33.25 – $36.66 |
| Typical daily range (% of price) | its price moves about 3.0% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.0% |
| Stretch from the 200-day average | it is trading 10.2 daily ranges above its 200-day average price (43.6% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 10.2 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.91× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 15.8% since the prior reading | +15.8% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
3
| Since a doji | today it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | today |
|---|---|---|
| Since a bullish engulfing | 7 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 7 sessions ago |
| Since a bearish engulfing | 8 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 8 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.4% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.4% |
|---|---|---|
| Open gap | it gapped 12.2% above the previous close 10 sessions ago and has not traded back through the level it left behind at 30.54 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +12.2% |
| Gap filled | a 2.1% gap up opened on 2026-08-20 has been "filled" 1 session ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 1 session ago |
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +0.66% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 7.8 percentage points (the stock gained 10.1% while the market gained 2.3%) | +7.8% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 33.7 percentage points (the stock gained 36.8% while the market gained 3.1%) | +33.7% |
| vs market, 6 months | over the past 6 months this stock beat the market by 36.8 percentage points (the stock gained 47.9% while the market gained 11.1%) | +36.8% |
| vs market, 12 months | over the past 12 months this stock beat the market by 31.6 percentage points (the stock gained 52.1% while the market gained 20.5%) | +31.6% |
Signal agreement
2
| Bullish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 16% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thick, spanning 8.4% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | +16.3% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 34% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $26.03 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | +34.5% |
|---|---|---|
| Vs the average paid since it last reported | the price is 2% above the average price paid since it last reported on 2026-08-06 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $34.20 — a volume-weighted average of daily closes over 12 sessions, not a true tick-by-tick VWAP. | +2.4% |
Price levels it has turned at before
CON last closed at $35.00 on 2026-08-21. Since 2024-08-21 it has turned at 11 prices below its last close and 0 above; the 3 nearest below are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $32.27 | Support | 7.8% below the last close | turned there twice · 2026-07-06 to 2026-07-16 |
| $30.19 | Support | 13.7% below the last close | turned there three times · 2026-07-14 to 2026-08-06 |
| $24.62 | Support | 29.7% below the last close | turned there four times · 2024-09-03 to 2026-06-01 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes below $30.13.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $32.98 and $34.75 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close below $30.13.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Near the 52-week high · in a strong, established uptrend (ADX) · Analyst price target recently RAISED · Near the all-time high · beating the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · all time high
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.22 mean, 1=Strong Buy…5=Strong Sell) — 8 analysts
- Mean price target$39.88 range $34.00 – $42.00; median $40.00
Analyst estimates, as of 2026-08-19. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for CON
- Consensus EPS estimate$0.4372 next reporting period, as of 2026-08-19
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Significant debt obligations and associated interest expense","Dependence on healthcare regulatory and reimbursement environments","Operational risks inherent in managing a large, distributed network of medical clinics"]
What changed in the latest 10-Q
AI-assisted comparison of CON's 10-Q filed 2026-05-07 against the prior one filed 2025-11-06.
Management's Discussion & Analysis (MD&A)
- Added:
- Added comprehensive opening language in newer filing (2026-05-07): 'The following discussion and analysis contains forward-looking statements that involve risks and uncertainties. When reviewing the discussion below, you should keep in mind the substantial risks and uncertainties that could impact our business. In particular, we encourage you to review the risks and uncertainties described in the sections titled "Risk Factors" and "Forward-Looking Statements" included in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026'
- Added to newer filing: 'Our historical results are not necessarily indicative of the results that may be expected for any period in the future, and our interim results are not necessarily indicative of the results we expect for the full fiscal year or any other period.'
- Added corporate structure explanation in newer filing: 'Concentra Group Holdings Parent, Inc., a Delaware corporation ("Concentra"), conducts substantially all of its business through Concentra Health Services, Inc. ("CHSI") and CHSI's subsidiaries.'
- Added risk factor in newer filing: 'The impacts of any security breaches, cyberattacks, loss of data, or cybersecurity threats or incidents involving our, or our third-party vendors', information technology systems, and any failure to comply with legal requirements related to data privacy, interoperability or data protection, including those governing the privacy and security of health information or other regulated, sensitive or confidential information'
- Added risk factor in newer filing: 'Our ability to manage relationships with managed affiliated professional medical groups ("Managed PCs")'
- Added risk factor in newer filing: 'Compliance with applicable data interoperability and information blocking rules'
- Updated operational metrics in newer filing: '632 stand-alone occupational health centers' and '411 onsite health clinics' as of March 31, 2026
- Removed:
- Removed from newer filing the risk factor: 'Our ability to achieve the expected benefits of and successfully execute the Separation and related transactions'
- Removed from newer filing: 'Restrictions on our business, potential tax and indemnification liabilities and substantial charges in connection with the Separation and related transactions'
- Removed from newer filing the risk factor: 'Compliance with applicable laws regarding the corporate practice of medicine and therapy and fee-splitting'
- Removed from newer filing language: 'similar to the COVID-19 pandemic' (following 'widespread outbreak of an infectious disease')
- Removed from newer filing: 'on the succession' (changed to 'and the succession')
- Removed from newer filing risk factor: 'Changes to United States tariff and import/export regulations and the impact on global economic conditions may have a negative effect on our business, financial condition and results of operations'
- Removed operational metrics from newer filing: '628 stand-alone occupational health centers' and '413 onsite health clinics' as of September 30, 2025
- Reworded:
- Older filing: 'You should read this discussion together with our unaudited condensed consolidated financial statements and accompanying notes.' Changed in newer filing to: 'The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q.'
- Older filing: 'This report on Form 10-Q contains forward-looking statements' changed to newer filing: 'This Quarterly Report on Form 10-Q contains forward-looking statements'
- Older filing: 'The adverse changes to our relationships' changed in newer filing to: 'Adverse changes to our relationships'
- Older filing: 'A security breach of our, or our third-party vendors', information technology systems which may cause a violation of HIPAA and subject us to potential legal and reputational harm' replaced in newer filing with broader cybersecurity risk language
- Older filing: 'Compliance with applicable data interoperability and information blocking rule' (singular) changed in newer filing to: 'Compliance with applicable data interoperability and information blocking rules' (plural)
- Older filing: 'Any negative impact on the global economy and capital markets resulting from other geopolitical tensions' changed in newer filing to: 'Any negative impact on the global economy and capital markets resulting from geopolitical tensions' (removed 'other')
- Older filing: 'and on the succession of our senior management' changed in newer filing to: 'and the succession of our senior management'
- Older filing: 'The negative impact of public threats such as a global pandemic or widespread outbreak of an infectious disease similar to the COVID-19 pandemic' changed in newer filing to: 'The negative impact of public threats such as a global pandemic or widespread outbreak of an infectious disease'
- Notes:
- Newer filing text is truncated at end of Overview section; older filing text is also truncated at similar point, limiting full comparison of Overview section
- Operational metrics changed from September 30, 2025 reporting date (older filing) to March 31, 2026 reporting date (newer filing), reflecting natural progression to subsequent quarter
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 2 open-market sales by insiders in the last 90 days.
- Last 90 days0 buys · 2 sells ($7M) — 1 selling insider
- Last 180 days0 buys · 3 sells ($10M) — 1 selling insider
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-07-01. As of 2026-08-25.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about CON's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 2 matched disclosures for CON from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Institutional ownership (13F)
4 institutional 13F filers reported holding CON as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 22,914,543
- Reported value $491,516,957
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 2 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
CON had 3,133,160 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
CON had 2.46% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 3.95 days to cover at the same settlement.
- Reported short interest (shares) 3,133,160
- Short interest (% of shares outstanding) 2.46%
- Prior settlement (shares) 3,383,343
- Reported change -7.39%
- Days to cover (reported) 3.95
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- U.S. Physical Therapy (USPH)
- HCA Healthcare (HCA)
- Tenet Healthcare (THC)
- CVS Health (CVS)
- Walgreens Boots Alliance (WBA)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CON vs…
Frequently asked questions
What does CONCENTRA GROUP HOLDINGS PARENT IN (CON) do?
Concentra Group Holdings Parent, Inc. provides occupational medicine and urgent care services. The company operates a national network of medical centers, delivering health services primarily to employees and employers, including injury care, physical therapy, and occupational health testing.
What sector is CONCENTRA GROUP HOLDINGS PARENT IN (CON) in?
CONCENTRA GROUP HOLDINGS PARENT IN (CON) is classified in the Health Care sector. Its industry is healthcare facilities / medical clinics. It trades on NYSE.
Does CON pay a dividend?
Yes — CONCENTRA GROUP HOLDINGS PARENT IN (CON) pays a dividend, with an indicated yield of about 0.90% and at least 2 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.
Who are CONCENTRA GROUP HOLDINGS PARENT IN's (CON) competitors?
Notable peers of CONCENTRA GROUP HOLDINGS PARENT IN (CON) include U.S. Physical Therapy, HCA Healthcare, Tenet Healthcare, CVS Health and Walgreens Boots Alliance. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in CON?
Yes — we hold 2 matched STOCK Act disclosures for CON from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is CONCENTRA GROUP HOLDINGS PARENT IN (CON) overbought or oversold right now?
CONCENTRA GROUP HOLDINGS PARENT IN (CON) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 65, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CON come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-24.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.